Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 22, 2015, 41 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $39.80 to $4,886,077.92.

Highlighted Stocks Traded by Insiders:

Streamline Health Solutions (STRM) - FREE Research Report

Turner Andrew L, who is Director at Streamline Health Solutions, sold 24,960 shares at $3.54 on Jan. 22, 2015. Following this transaction, the Director owned 64,553 shares meaning that the stake was reduced by 27.88% with the 24,960-share transaction.

Kaplan Michael K, who is Director at Streamline Health Solutions, bought 5,000 shares at $3.54 on Jan. 22, 2015. Following this transaction, the Director owned 67,815 shares meaning that the stake was boosted by 7.96% with the 5,000-share transaction.

Starkey Judith, who is Director at Streamline Health Solutions, bought 5,000 shares at $3.54 on Jan. 22, 2015. Following this transaction, the Director owned 25,433 shares meaning that the stake was boosted by 24.47% with the 5,000-share transaction.

Meeks Nicholas, who is Chief Financial Officer at Streamline Health Solutions, bought 1,000 shares at $3.54 on Jan. 22, 2015. Following this transaction, the Chief Financial Officer owned 5,796 shares meaning that the stake was boosted by 20.85% with the 1,000-share transaction.

Rickard Lois Elizabeth, who is SVP & Chief People Officer at Streamline Health Solutions, bought 2,000 shares at $3.54 on Jan. 22, 2015. Following this transaction, the SVP & Chief People Officer owned 7,000 shares meaning that the stake was boosted by 40% with the 2,000-share transaction.

The shares most recently traded at $3.71, up $0.17, or 4.67% since the insider transaction. Historical insider transactions for Streamline Health Solutions go as follows:

  • 4-Week # shares bought: 13,000
  • 4-Week # shares sold: 25,000
  • 12-Week # shares bought: 13,000
  • 12-Week # shares sold: 25,000
  • 24-Week # shares bought: 92,000
  • 24-Week # shares sold: 17,567

The average volume for Streamline Health Solutions has been 41,700 shares per day over the past 30 days. Streamline Health Solutions has a market cap of $69.3 million and is part of the technology sector and computer software & services industry. Shares are down 15.01% year-to-date as of the close of trading on Thursday.

Streamline Health Solutions, Inc. provides health information technology solutions and services for hospitals, healthcare organizations, and physician practices in the United States and Canada. Currently, there are 2 analysts who rate Streamline Health Solutions a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on STRM - FREE

TheStreet Quant Ratings

rates Streamline Health Solutions as a

sell

. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

Streamline Health Solutions Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Vantiv (VNTV) - FREE Research Report

Greene Nelson F, who is Chief Legal Officer & Sec. at Vantiv, sold 7,735 shares at $34.06 on Jan. 22, 2015. Following this transaction, the Chief Legal Officer & Sec. owned 82,171 shares meaning that the stake was reduced by 8.6% with the 7,735-share transaction.

The shares most recently traded at $34.58, up $0.52, or 1.51% since the insider transaction. Historical insider transactions for Vantiv go as follows:

  • 4-Week # shares sold: 2,414
  • 12-Week # shares sold: 25,614
  • 24-Week # shares sold: 61,115

The average volume for Vantiv has been 1.3 million shares per day over the past 30 days. Vantiv has a market cap of $4.9 billion and is part of the services sector and diversified services industry. Shares are up 0.68% year-to-date as of the close of trading on Thursday.

Vantiv, Inc. provides electronic integrated payment processing services in the United States. It operates in two segments, Merchant Services and Financial Institution Services. The company has a P/E ratio of 52.1. Currently, there are 13 analysts who rate Vantiv a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VNTV - FREE

TheStreet Quant Ratings

rates Vantiv as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Vantiv Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Equinix (EQIX) - FREE Research Report

Schwartz Eric, who is President, Equinix Europe at Equinix, sold 1,268 shares at $220.29 on Jan. 22, 2015. Following this transaction, the President, Equinix Europe owned 5,650 shares meaning that the stake was reduced by 18.33% with the 1,268-share transaction.

The shares most recently traded at $230.96, up $10.67, or 4.62% since the insider transaction. Historical insider transactions for Equinix go as follows:

  • 4-Week # shares sold: 12,035
  • 12-Week # shares sold: 12,035
  • 24-Week # shares sold: 12,035

The average volume for Equinix has been 633,500 shares per day over the past 30 days. Equinix has a market cap of $11.9 billion and is part of the technology sector and internet industry. Shares are up 1.07% year-to-date as of the close of trading on Thursday.

Equinix, Inc. provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company has a P/E ratio of 81.5. Currently, there are 9 analysts who rate Equinix a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on EQIX - FREE

TheStreet Quant Ratings

rates Equinix as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Equinix Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null